Triventures is the famous VC, which was founded in 2008. The venture was found in Asia in Israel. The leading representative office of defined VC is situated in the Herzliya.
Among the most popular portfolio startups of the fund, we may highlight Cala Health, V-Wave, Cardiva Medical. Among the most successful fund investment fields, there are Machine Learning, Medical. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
This organization was formed by Martin Leon, Michal Geva, Peter Fitzgerald. Besides them, we counted 3 critical employees of this fund in our database.
The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2015. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. This Triventures works on 17 percentage points less the average amount of lead investments comparing to the other organizations.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Triventures, startups are often financed by lool ventures, Sycamore Ventures, Galen Partners. The meaningful sponsors for the fund in investment in the same round are lool ventures, Pontifax, Pitango Venture Capital. In the next rounds fund is usually obtained by lool ventures, Pitango Venture Capital, 7wire Ventures.
Funds with similar focus
|5i5j.com||Beijing, Beijing, China|
|Archangel||New York, New York, United States|
|Blast Off Partners S.L||Comunidad Valenciana, Spain, Valencian Community|
|Bo Fu (Shanghai) Qiye Fazhan Co., Ltd||China, Huangpu, Shanghai|
|Cloud Fund Partners||-|
|FCP Biotech Holding||Bayern, Germany, Gräfelfing|
|Huayi Ziben||China, Jiading District|
|Ideabox||Indonesia, Jakarta, Jakarta Raya|
|M&T Bank||Buffalo, New York, United States|
|Nedbank||Gauteng, NA - South Africa, South Africa|
|PYN Fund Management||Finland, Helsinki, Southern Finland|
|Rio Bravo||Brazil, São Paulo, Sao Paulo|
|Riverstone Energy||Castel, Guernsey, Guernsey|
|ShakeUpFactory||France, Ile-de-France, Paris|
|Suzhou Jusong||China, Jiangsu, Suzhou|
|Taikang Asset||Beijing, Beijing, China|
|Teal Ventures||California, San Diego, United States|
|UTI Ventures||Bangalore, India, Karnataka|
|$25M||04 Apr 2022||San Francisco, California, United States|
|$3M||01 Apr 2022||Gilbert, Arizona, United States|
|$50M||29 Mar 2022||San Francisco, California, United States|
Day Zero Diagnostics
|$21M||09 Feb 2022||Boston, Massachusetts, United States|
|$11M||09 Jun 2021||Tel Aviv-Yafo, Tel Aviv District, Israel|
|$20M||07 Jun 2021||Tel Aviv-Yafo, Tel Aviv District, Israel|
|$10M||29 Apr 2021||New York, New York, United States|
|$25M||15 Mar 2021||Jerusalem, Jerusalem District, Israel|
|$3M||02 Mar 2021||Gilbert, Arizona, United States|
– Genoox is a Palo Alto in CA-based driven genomic data platform provider.
– The company raised $8m in funding.
– The round was led by IN Venture, a Sumitomo Corporation backed venture fund, with participation from Infinity Medical and existing investors Inimiti, Glilot Capital and Triventures.
– The new funding will be used to expand its community of genetic professional users and enhance the network effect created by sharing genetic insights on its platform.
– Grin is a NYC-based comprehensive digital platform that provides orthodontic solutions.
– The company raised $10m in funding.
– The round was led by Triventures with participation from Procter & Gamble Oral Care (NYSE: PG) and SpringRock Ventures.
– The new investment will be used to invest in technological innovations, onboard talent, and enhance their orthodontic partner network.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.